Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

VMD publishes EU exit advice for vets
In the event of a no-deal Brexit, the key areas in which vets will need to do things differently are operating the prescribing cascade and applying for a Special Import Certificate.
Information hub aids preparations for no deal scenario 

The Veterinary Medicines Directorate (VMD) has launched an information hub to help vets prepare for Brexit, including what will change if the UK leaves the EU without a deal.

In the event of a no-deal Brexit, the key areas in which vets will need to do things differently are operating the prescribing cascade and applying for a Special Import Certificate.

From EU Exit Day (29 March 2019), the UK would have to follow World Trade Organisation rules, if a deal is not reached. As a result, we would no longer be able to show preference to EU medicines over those from other countries when prescribing under the cascade.

Whether a deal is reached or not, after Brexit the VMD will no longer issue Special Treatment Certificates. Only Special Import Certificates (SICs) will be available to vets importing medicines for veterinary use.

SICs will be issued for veterinary medicines authorised outside of the UK, human medicines authorised outside the UK, or in very exceptional cases, unauthorised medicines from outside the UK.

For further information and updates on what will and will not change after Brexit, visit the EU Exit Information Hub.

Become a member or log in to add this story to your CPD history

Greyhound Board announces change to vaccination guidance

News Story 1
 The Greyhound Board of Great Britain has published new vaccination guidance, with all greyhounds registered from 1 January, 2027 required to have the L4 leptospirosis vaccination, rather than L2.

The change comes in response to the reduced availability of the 'L2' Leptospirosis vaccine across the UK, and aims to support best biosecurity practice across the racing greyhound population.

GBGB veterinary director Simon Gower, said "While rare, Leptospirosis is a serious infectious disease that can affect both dogs and humans, so it is vital that we offer our greyhounds the broadest possible protection.  

Click here for more...
News Shorts
Free webinar explores congenital heart disease in dogs

A free webinar is to provide veterinary professionals, dog breeders and pet owners an new insights into congenital heart disease.

Chris Linney, a cardiology specialist and Veterinary Cardiovascular Society (VSC) member, will present the webinar from 7.00pm to 8.30pm on Wednesday, 12 November.

Dr Linney will explore the types, causes and clinical presentation of congenital heart conditions. This will include diagnostic approaches, treatment pathways and emerging research opportunities.

The session is the third to be organised by The Kennel Club, with the VCS, following an introductory webinar and a talk on acquired heart disease. Dr Linney's webinar consists of a one-hour presentation, followed by a 30-minute question and answer session.

Dr Linney said: "This webinar will be an opportunity to deepen understanding - not just of the diseases themselves, but of how breeders, vets and owners can work together to support affected dogs and improve outcomes for future generations."

Click here to register for the webinar.